loading
Autolus Therapeutics Plc Adr stock is traded at $2.925, with a volume of 1.56M. It is down -5.19% in the last 24 hours and down -39.17% over the past month. Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
See More
Previous Close:
$3.08
Open:
$3.24
24h Volume:
1.56M
Relative Volume:
1.29
Market Cap:
$819.57M
Revenue:
-
Net Income/Loss:
$-208.38M
P/E Ratio:
-2.458
EPS:
-1.19
Net Cash Flow:
$-156.57M
1W Performance:
-16.81%
1M Performance:
-39.17%
6M Performance:
-33.49%
1Y Performance:
-34.38%
1-Day Range:
Value
$2.92
$3.25
1-Week Range:
Value
$2.92
$3.72
52-Week Range:
Value
$2.92
$7.45

Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile

Name
Name
Autolus Therapeutics Plc Adr
Name
Phone
44 20 3829 6230
Name
Address
THE MEDIAWORKS, LONDON
Name
Employee
463
Name
Twitter
Name
Next Earnings Date
2024-12-12
Name
Latest SEC Filings
Name
AUTL's Discussions on Twitter

Compare AUTL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
AUTL 2.93 819.57M 0 -208.38M -156.57M -1.19
VRTX 467.14 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.26 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 565.93 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.62 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.14 24.08B 3.30B -501.07M 1.03B 11.54

Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-09-23 Initiated Deutsche Bank Buy
Mar-27-23 Resumed Wells Fargo Overweight
Mar-17-23 Initiated Bryan Garnier Buy
Jun-14-21 Upgrade Jefferies Hold → Buy
Jan-29-21 Downgrade JP Morgan Overweight → Neutral
Dec-28-20 Resumed H.C. Wainwright Buy
Jul-31-20 Initiated JP Morgan Overweight
Jul-22-20 Initiated SunTrust Buy
Apr-22-20 Initiated Mizuho Buy
Sep-23-19 Initiated Needham Buy
May-17-19 Reiterated H.C. Wainwright Buy
Oct-24-18 Initiated H.C. Wainwright Buy
View All

Autolus Therapeutics Plc Adr Stock (AUTL) Latest News

pulisher
Nov 15, 2024

Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com

Nov 15, 2024
pulisher
Nov 06, 2024

Does MP Materials Corporation (NYSE: MP) Still Need To Convince Analysts? - Stocks Register

Nov 06, 2024
pulisher
Nov 06, 2024

Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register

Nov 06, 2024
pulisher
Oct 14, 2024

PDD Holdings Inc ADR (NASDAQ: PDD) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Do Wall Street Analysts Think About Moderna Inc (NASDAQ: MRNA) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This Autolus Therapeutics plc ADR (NASDAQ: AUTL) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

Autolus Therapeutics plc ADR (AUTL)’s stock rises to 4.14 per share - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Autolus Therapeutics plc ADR: -44.83% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

A better buy-in window may exist right now for Autolus Therapeutics plc ADR (AUTL) - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Upward Trajectory: Autolus Therapeutics plc ADR (AUTL) Posts a Slidee, Closing at 3.98 - The Dwinnex

Oct 10, 2024
pulisher
Oct 08, 2024

Autolus Therapeutics plc ADR (AUTL) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Oct 08, 2024
pulisher
Oct 04, 2024

Are Smart Investors Making the Right Decision? Autolus Therapeutics plc ADR (AUTL) - SETE News

Oct 04, 2024
pulisher
Oct 03, 2024

Autolus Therapeutics plc ADR (AUTL) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Oct 03, 2024
pulisher
Oct 02, 2024

Autolus Therapeutics plc ADR (AUTL)’s stock chart: A technical perspective - US Post News

Oct 02, 2024
pulisher
Sep 30, 2024

Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 3.63, Up by 4.31 - The Dwinnex

Sep 30, 2024
pulisher
Sep 25, 2024

A look into Autolus Therapeutics plc ADR (AUTL)’s deeper side - SETE News

Sep 25, 2024
pulisher
Sep 24, 2024

Are Autolus Therapeutics plc ADR (AUTL) shares a good deal now? - US Post News

Sep 24, 2024
pulisher
Sep 23, 2024

Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.73, Down -3.12 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Autolus Therapeutics (NASDAQ:AUTL) Shares Down 4.8% - MarketBeat

Sep 23, 2024
pulisher
Sep 19, 2024

Autolus Therapeutics names new Chief Development Officer - Investing.com India

Sep 19, 2024
pulisher
Sep 19, 2024

Autolus Therapeutics names new Chief Development Officer By Investing.com - Investing.com South Africa

Sep 19, 2024
pulisher
Sep 18, 2024

Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Down 8.0% in August - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Autolus Therapeutics plc ADR (AUTL) looking to reclaim success with recent performance - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Autolus Therapeutics plc ADR (AUTL) Stock: Navigating a Year of Volatility - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Autolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Daiwa Securities Group Inc. - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Autolus Therapeutics plc ADR (AUTL)’s stock price in review: A technical analysis - US Post News

Sep 17, 2024
pulisher
Sep 16, 2024

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.08 - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Financial Metrics Check: Autolus Therapeutics plc ADR (AUTL)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 16, 2024
pulisher
Sep 13, 2024

Autolus secures £18.5M for facility upgrades - Investing.com

Sep 13, 2024
pulisher
Sep 11, 2024

Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter - SETE News

Sep 11, 2024
pulisher
Sep 11, 2024

Trading Day Review: Autolus Therapeutics plc ADR (AUTL) Gains Momentum, Closing at 4.12 - The Dwinnex

Sep 11, 2024
pulisher
Sep 10, 2024

Autolus Therapeutics plc ADR (AUTL) presents a great opportunity, but the stock is slightly overvalued - US Post News

Sep 10, 2024
pulisher
Sep 09, 2024

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 6% - MarketBeat

Sep 09, 2024
pulisher
Sep 06, 2024

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 3.4% - MarketBeat

Sep 06, 2024
pulisher
Sep 04, 2024

It is Poised to be a Bull Market for Autolus Therapeutics plc ADR (AUTL) - SETE News

Sep 04, 2024
pulisher
Sep 04, 2024

Contrasting Autolus Therapeutics (NASDAQ:AUTL) & ZIVO Bioscience (NASDAQ:ZIVO) - Defense World

Sep 04, 2024
pulisher
Sep 02, 2024

Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today - GlobeNewswire Inc.

Sep 02, 2024
pulisher
Aug 27, 2024

Autolus reports promising results for obe-cel in leukemia study - Investing.com India

Aug 27, 2024
pulisher
Aug 22, 2024

Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - SETE News

Aug 22, 2024
pulisher
Aug 20, 2024

Is Autolus Therapeutics plc ADR (AUTL) a good investment opportunity? - US Post News

Aug 20, 2024
pulisher
Aug 20, 2024

SG Americas Securities LLC Purchases 169,387 Shares of Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World

Aug 20, 2024
pulisher
Aug 16, 2024

Take off with Autolus Therapeutics plc ADR (AUTL): Get ready for trading - SETE News

Aug 16, 2024
pulisher
Aug 15, 2024

Examining Autolus Therapeutics plc ADR (AUTL) stock is warranted - US Post News

Aug 15, 2024
pulisher
Aug 14, 2024

Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.75, Up 1.90 - The Dwinnex

Aug 14, 2024
pulisher
Aug 13, 2024

Financial Survey: Autolus Therapeutics (NASDAQ:AUTL) and Cognition Therapeutics (NASDAQ:CGTX) - Defense World

Aug 13, 2024
pulisher
Aug 11, 2024

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $3.64 - Defense World

Aug 11, 2024
pulisher
Aug 10, 2024

Cetera Advisors LLC Invests $839,000 in Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World

Aug 10, 2024
pulisher
Aug 07, 2024

How Analyst Ratings Affect Autolus Therapeutics plc ADR Inc. (AUTL) Price Performance - The InvestChronicle

Aug 07, 2024
pulisher
Aug 07, 2024

Understanding the Risks and Rewards of Investing in SES AI Corporation Inc. (SES) Based on Price Performance - The InvestChronicle

Aug 07, 2024
pulisher
Aug 07, 2024

Aptiv PLC: Rising -36.09% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle

Aug 07, 2024
pulisher
Aug 07, 2024

i-80 Gold Corp (IAUX) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Aug 07, 2024

Autolus Therapeutics Plc Adr Stock (AUTL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.04
price down icon 0.87%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):